Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1768594016 | Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1779899014 | Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1787308017 | Diatrizoate meglumine 30% injection | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3106481000052118 | meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Is a | Amidotrizoate-containing product | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has active ingredient | Amidotrizoate | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Is a | jodprodukt | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Is a | meglumindiatrizoat | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has active ingredient | Iodine | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has active ingredient | Meglumine amidotrizoate | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has active ingredient | Iodine compound | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has active ingredient | jod och/eller jodförening | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
| meglumindiatrizoat 300 mg + jod 141 mg/ml (30 %), injektionsvätska, lösning, flaska 50 ml | Is a | megluminamidotrizoat för parenteralt bruk | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR